BTN3A2 and neoplasm: At present, it has been confirmed that BTN3A1 can kill tumor cells by activating Vγ9Vδ2 T cells, which indicates that it is related to tumor immunity (20, 21), but little is known about BTN3A2 and BTN3A3.